Clinical trials begin in DRC epicenter of Bundibugyo strain of Ebola

Clinical trials have commenced in the Democratic Republic of Congo to develop treatments for the Bundibugyo strain of Ebola, which has already claimed over 450 lives among nearly 1,500 confirmed cases. This effort is crucial as Bundibugyo, though less deadly than other strains like Zaire, still poses a significant health threat. Successfully developing a treatment could greatly improve survival rates and help manage future outbreaks of this strain.